Scott A. Tomlins

Scott A. Tomlins is an Adjunct Associate Professor of Pathology and Urology at the University of Michigan Medical School. His research focuses on molecular pathology, oncology, and the development of precision medicine approaches through genomic and biomarker analyses. He is affiliated with the Taubman Institute, Center for Computational Medicine and Bioinformatics, and the Rogel Cancer Center.

His work emphasizes translational research in cancer biomarkers, including studies on lung, prostate, and uterine tumors. Key areas include genomic profiling of metastatic cancers, immune landscape characterization, and predictive biomarkers for therapies like immunotherapy and antibody-drug conjugates.

Tomlins collaborates extensively, as evidenced by his recent publications on multi-region molecular profiling in prostate cancer and ADC response prediction. No scientific awards are listed, but he is actively involved in mentoring and grant-related activities through his institutional affiliations.

His lab and team contributions are embedded in the mentioned centers, focusing on integrating computational and experimental methods to advance cancer diagnostics and treatment strategies.